DocMorris AG (DOCM) Earnings Call Transcripts

DocMorris AG's Latest Earnings Call - Q1 FY2026

DocMorris AG reported strong Q1 2026 results, with revenue growing 10.7% YoY and a significant improvement in adjusted EBITDA by CHF 10 million to minus CHF 6 million. The company highlighted a 30.4% YoY growth in its Rx business and a 63.1% increase in its Digital Services segment. Management reiterated its guidance for EBITDA breakeven in 2026, maintaining its adjusted EBITDA target range of minus CHF 10 million to minus CHF 25 million for the year.

Reported metrics

Guidance from management

Management maintained its guidance for 2026, targeting an adjusted EBITDA range of minus CHF 10 million to minus CHF 25 million, with a commitment to achieving EBITDA breakeven by Q4 2026.

What management said

Yes. Thank you, Jan, for your questions. Let me take the first and third question. And then the second one, I would like to hand over to Daniel. On the Rx, what I just can confirm that we continuously improve the marketing mix, the performance of the marketing. And with that, we just see a really good development. And yes, so let's meet again in August, and then I can further -- or we can further give you more detail...

Okay. And then coming to your third question about the regulatory development, and you mentioned the cold chain. So as you all know, there is a draft of regulation, which has been issued by the Ministry of Health. And now the EU Commission intervened and basically said that it's a violation of EU law again, we have to say. For us, it's a positive signal because we see it equally. So now the ministry has to adjust thi...

What analysts pressed on

Analysts questioned the conservativeness of full-year guidance given the strong Q1 performance, particularly in the Rx segment. Concerns were also raised about potential regulatory changes affecting the cold chain requirements.

Main topics on the call

• Revenue Growth — DocMorris achieved a 10.7% YoY revenue growth in Q1 2026, driven by a 30.4% increase in the Rx business and a 63.1% growth in Digital Services. Management emphasized the success of their strategy to capture the Rx market...
• Digital Services Expansion — Digital Services, including TeleClinic and Retail Media, grew by 63.1% in Q1 2026, contributing significantly to EBITDA. Management noted, 'These digital business lines are not just growing top line, they are delivering ...
• EBITDA Improvement — Adjusted EBITDA improved by CHF 10 million YoY to minus CHF 6 million, with the margin improving by over 360 basis points. Management attributed this to better operational performance and disciplined cost management.
• Customer Base Growth — The active customer base expanded by 1 million YoY to 12.6 million, with 0.4 million added in Q1 2026. This growth supports the company's ecosystem platform expansion.

Read the full DocMorris AG transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 16 DocMorris AG earnings call transcripts on record, spanning March 19, 2020 to April 16, 2026. Based on this history, DocMorris AG reports semi-annually. The most recent call on file is dated April 16, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

DOCM

Exchange

SWX

Country

CH

Sector

Consumer Staples

Industry

Consumer Staples Distribution and Retail

Calls on record

16

First call

March 19, 2020

Most recent

April 16, 2026

Reporting cadence

semi-annually